Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation.
Toxoplasma gondii may cause severe infections in immunocompromised patients including fetuses and those with AIDS. Among the factors mediating protection against T. gondii, IFN-gamma has gained special attention. To analyze the role of IFN-gamma in the early phase of toxoplasmosis, IFN-gamma receptor-deficient (IFN-gamma R0/0) mice were orally infected with low-virulent toxoplasms. IFN-gamma R0/0 mice died of the disease up to day 10 postinfection, whereas immunocompetent wild-type (WT) mice developed a chronic toxoplasmosis. Histopathology revealed that in IFN-gamma R0/0 mice, the parasite multiplied unrestrictedly in the small intestine, the intestinal lymphatic tissue, the liver, and the spleen. Ultimately, animals died of a necrotizing hepatitis. In WT mice, the same organs were effected, but multiplication of the parasite was effectively limited. Compared with WT mice, immunohistochemistry and flow cytometry demonstrated that in IFN-gamma R0/0 mice, macrophages were only marginally activated in response to the infection, as evidenced by a reduced expression of major histocompatability complex class II antigens. In addition, immunohistochemistry and RT-PCR showed a reduced production of the macrophage-derived cytokines tumor necrosis factor-alpha, inducible nitric oxide synthase, and IL-1 beta in the liver of IFN-gamma R0/0 mice. In contrast, activation of T cells, recruitment of immune cells to inflammatory foci, and anti-T. gondii IgM antibody production were unaffected by the mutation of the IFN-gamma R. Moreover, induction of IL-2, IL-4, and IL-10 mRNA transcripts in the liver was normal in IFN-gamma R0/0 mice. Adoptive transfer experiments revealed that the immune T cells of WT animals did not protect IFN-gamma R0/0 mice from lethal infection with highly virulent toxoplasms, whereas WT mice were significantly protected by the adoptive transfer. Based on these studies, we conclude that IFN-gamma is absolutely required for an efficient activation of macrophages. Macrophages are of critical importance in toxoplasmosis, and insufficient macrophage activation cannot be compensated by other immune mechanisms.
Deckert-Schlüter
M
M
Institut für Neuropathologie, Universitätskliniken Bonn, Germany.
Rang
A
A
Weiner
D
D
Huang
S
S
Wiestler
O D
OD
Hof
H
H
Schlüter
D
D
D019264:Adoptive Transfer; D000818:Animals; D015703:Antigens, CD / Q000235:genetics* / Q000502:physiology*; D016207:Cytokines / Q000096:biosynthesis*; D020022:Genetic Predisposition to Disease; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis; D007421:Intestine, Small / Q000469:parasitology / Q000473:pathology; D007962:Leukocytes / Q000276:immunology / Q000473:pathology; D008099:Liver / Q000276:immunology / Q000469:parasitology / Q000473:pathology; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology / Q000473:pathology; D051379:Mice; D008815:Mice, Inbred Strains; D008817:Mice, Mutant Strains; D019001:Nitric Oxide Synthase / Q000096:biosynthesis; D016133:Polymerase Chain Reaction; D017471:Receptors, Interferon / Q000235:genetics* / Q000502:physiology*; D013154:Spleen / Q000276:immunology / Q000473:pathology; D014122:Toxoplasma / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity; D014124:Toxoplasmosis, Animal / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D014158:Transcription, Genetic; D014774:Virulence; D000096743:Interferon gamma Receptor
D015703:Antigens, CD; D016207:Cytokines; D000949:Histocompatibility Antigens Class II; D019001:Nitric Oxide Synthase; D017471:Receptors, Interferon; D000096743:Interferon gamma Receptor